Topical Ivermectin 10 mg/g and Oral Doxycycline 40 mg Modified-Release: Current Evidence on the Complementary Use of Anti-Inflammatory Rosacea Treatments
Crossref DOI link: https://doi.org/10.1007/s12325-016-0380-z
Published Online: 2016-07-18
Published Print: 2016-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Steinhoff, Martin
Vocanson, Marc
Voegel, Johannes J
Hacini-Rachinel, Feriel
Schäfer, Gregor
Funding for this research was provided by:
Galderma